Literature DB >> 7402591

The place of timolol in the practice of ophthalmology.

R P Wilson, G L Spaeth, E Poryzees.   

Abstract

Timolol has become so populat with ophthalmologists that it is prescribed 44% of the time when an anti-glaucoma drop is needed. This popularity is due to its newness and the publicity it has received, its effectiveness in most types of glaucoma, and the apparent scarcity of side effects. This paper looks at the first 489 patients treated with timolol at Wills Eye Hospital and the side effects encountered. These include blurring of vision, burning and pain, bradycardia and heart failure, hallucinations, dilated pupils, headaches, dizziness, hypotony, allergy, asthma, impotence, drowsiness, anxiety, emotional lability, and nausea.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7402591     DOI: 10.1016/s0161-6420(80)35214-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Effects of long-term topical anti-glaucoma medications on meibomian glands.

Authors:  Reiko Arita; Kouzo Itoh; Shuji Maeda; Koshi Maeda; Ayumu Furuta; Atsuo Tomidokoro; Makoto Aihara; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

Review 2.  Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.

Authors:  Nevio Cimolai
Journal:  Clin Med Res       Date:  2019-08-28

3.  Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma.

Authors:  K B Mills
Journal:  Br J Ophthalmol       Date:  1983-04       Impact factor: 4.638

4.  Short-term and long-term timolol maleate effects on corneal sensitivity.

Authors:  D Spinelli; F Vigasio; P Montanari
Journal:  Doc Ophthalmol       Date:  1984-02-29       Impact factor: 2.379

5.  Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.

Authors:  Takeo Fukuchi; Kimiko Wakai; Kieko Suda; Tomoko Nakatsue; Hideko Sawada; Hiroaki Hara; Jun Ueda; Takayuki Tanaka; Akiko Yamada; Haruki Abe
Journal:  Clin Ophthalmol       Date:  2010-04-26

6.  Timolol treatment of chronic open-angle glaucoma and ocular hypertension. A 2.5-year multicenter study.

Authors:  P J Airaksinen; O Valle; K K Takki; A Klemetti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

7.  The influence of long-term treatment with timolol on human tear lysozyme albumin content.

Authors:  G Strasser; G Grabner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

8.  The effect of long-term topical administration of commercial beta-blockers on the rat corneal endothelium.

Authors:  M Matsuda; Y Ishii; T Awata; M Fukuda
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

9.  Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis.

Authors:  Jayant Venkatramani Iyer; Yang Zhao; Fiona Pin Miao Lim; Louis Tong; Tina Tzee Ling Wong
Journal:  Clin Ophthalmol       Date:  2017-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.